KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

LifeMD (LFMD) Other Operating Expenses (2016 - 2025)

LifeMD's Other Operating Expenses history spans 11 years, with the latest figure at -$24.5 million for Q4 2025.

  • For Q4 2025, Other Operating Expenses fell 160.32% year-over-year to -$24.5 million; the TTM value through Dec 2025 reached $61.5 million, down 12.6%, while the annual FY2025 figure was $76.7 million, 24.94% up from the prior year.
  • Other Operating Expenses reached -$24.5 million in Q4 2025 per LFMD's latest filing, down from $33.9 million in the prior quarter.
  • In the past five years, Other Operating Expenses ranged from a high of $33.9 million in Q3 2025 to a low of -$24.5 million in Q4 2025.
  • Average Other Operating Expenses over 5 years is $18.1 million, with a median of $23.6 million recorded in 2021.
  • Peak YoY movement for Other Operating Expenses: skyrocketed 9577.9% in 2023, then tumbled 160.32% in 2025.
  • A 5-year view of Other Operating Expenses shows it stood at $23.9 million in 2021, then rose by 1.17% to $24.2 million in 2022, then dropped by 0.4% to $24.1 million in 2023, then tumbled by 139.06% to -$9.4 million in 2024, then plummeted by 160.32% to -$24.5 million in 2025.
  • Per Business Quant, the three most recent readings for LFMD's Other Operating Expenses are -$24.5 million (Q4 2025), $33.9 million (Q3 2025), and $24.5 million (Q2 2025).